These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21861940)

  • 1. Health benefits and health claims of probiotics: bridging science and marketing.
    Rijkers GT; de Vos WM; Brummer RJ; Morelli L; Corthier G; Marteau P
    Br J Nutr; 2011 Nov; 106(9):1291-6. PubMed ID: 21861940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics.
    Binnendijk KH; Rijkers GT
    Benef Microbes; 2013 Sep; 4(3):223-30. PubMed ID: 23685375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Health and nutrition claims made on food: what future?].
    Laplace JP
    Bull Acad Natl Med; 2006 Nov; 190(8):1663-80; discussion 1680-2. PubMed ID: 17650751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics and European Food Safety Authority health claims.
    Capurso L; Morelli L
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S1. PubMed ID: 20716983
    [No Abstract]   [Full Text] [Related]  

  • 5. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why the European Food Safety Authority was right to reject health claims for probiotics.
    Katan MB
    Benef Microbes; 2012 Jun; 3(2):85-9. PubMed ID: 22683835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics--the friendly bacteria with market potential in global market.
    Khan SH; Ansari FA
    Pak J Pharm Sci; 2007 Jan; 20(1):76-82. PubMed ID: 17337434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 13. Current marketplace for probiotics: a Japanese perspective.
    Amagase H
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PASSCLAIM - Synthesis and review of existing processes.
    Richardson DP; Affertsholt T; Asp NG; Bruce A; Grossklaus R; Howlett J; Pannemans D; Ross R; Verhagen H; Viechtbauer V
    Eur J Nutr; 2003 Mar; 42 Suppl 1():I96-111. PubMed ID: 12664324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer understanding of nutrition and health claims: sources of evidence.
    Leathwood PD; Richardson DP; Sträter P; Todd PM; van Trijp HC
    Br J Nutr; 2007 Sep; 98(3):474-84. PubMed ID: 17705892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ascent of the blessed: regulatory issues on health effects and health claims for probiotics in Europe and the rest of the world.
    Dronkers TMG; Krist L; Van Overveld FJ; Rijkers GT
    Benef Microbes; 2018 Sep; 9(5):717-723. PubMed ID: 29798707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic and therapeutic uses of probiotics: a review.
    Kopp-Hoolihan L
    J Am Diet Assoc; 2001 Feb; 101(2):229-38; quiz 239-41. PubMed ID: 11271697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of probiotic studies to substantiate health claims.
    Gibson GR; Brummer RJ; Isolauri E; Lochs H; Morelli L; Ockhuizen T; Rowland IR; Schrezenmeir J; Stanton C; Verbeke K
    Gut Microbes; 2011 Sep; 2(5):299-305. PubMed ID: 22067941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics: facts and myths.
    Senok AC; Ismaeel AY; Botta GA
    Clin Microbiol Infect; 2005 Dec; 11(12):958-66. PubMed ID: 16307549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
    Saxelin M
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.